Taylor, Peter C. http://orcid.org/0000-0001-7766-6167
Article History
First Online: 12 October 2023
Competing interests
: P.C.T. declares that he has received consulting fees from AbbVie, Biogen, Bristol Myers Squibb, Fresenius, Galapagos, Gilead Sciences, GSK, Janssen, Lilly, Nordic Pharma, Pfizer, Roche, Sanofi and UCB, and research support to the University of Oxford from Galapagos.